Oxford spinout Celleron Therapeutics raises funding from South Korean consortium of investors for small molecule treatments.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
OxSonics, an Oxford University spinout established in 2013 to develop ultrasound therapeutics, has secured £9.4m in series B equity financing, bringing its total external fundraising to £14.2m.
Oxford University Innovation launches 24 companies in 2016 with a combined £52.6m in early stage funding, setting a new record in spinout generation for the UK and Europe.
HTC Vive and virtual reality distance learning platform Engage to showcase the LIFE project from the University of Oxford.
Oxford University spinout PrOXisense secures £330,000 in round led by Parkwalk Advisors for the development of sensors in extreme environments.
Circadian Therapeutics aims to develop therapeutics and diagnostics for modulation of the body's circadian rhythms.
Oxford University forms spinout company to bring fast, cost-effective enzyme development to market.
Oxford University spinouts Genomics and Nanopore partner on utilising handheld nanopore technologies for DNA sequencing.